Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
暂无分享,去创建一个
T. Yoshida | Taku Yoshida | M. Uesugi | Y. Funahashi | J. Matsui | G. Kuznetsov | S. Agoulnik | Y. Sato | Yoshiaki Sato | Y. Ozawa | T. Kimura | Shanqin Xu | Y. Ozawa | N. Taylor | Takayuki Kimura | S. Xu | S. Xu | Mai Uesugi | Noel Taylor